Stocktoria
Corbus Pharmaceuticals Holdings, Inc. CRBP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-10-24
Chart by TradingView
1/9
Piotroski F — financial health
-0.98
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | — | — | — | $0 | $881,705 |
| Operating income | -$85.3M | -$48.7M | -$45.1M | -$39.8M | -$56.0M |
| Net income | -$78.5M | -$40.2M | -$44.6M | -$42.3M | -$45.6M |
| Operating cash flow | -$64.5M | -$41.8M | -$36.1M | -$37.5M | -$48.2M |
| Free cash flow | -$64.5M | -$41.8M | -$36.1M | -$37.6M | -$48.2M |
| Total assets | $168.2M | $155.9M | $28.3M | $66.3M | $107.7M |
| Total liabilities | $20.7M | $13.5M | $35.2M | $33.3M | $38.6M |
| Shareholders' equity | $147.5M | $142.4M | -$6.9M | $33.0M | $69.1M |
| Ratios | |||||
| Operating margin | — | — | — | — | -6350.1% |
| Net margin | — | — | — | — | -5176.4% |
| FCF margin | — | — | — | — | -5471.0% |
| Return on assets | -46.7% | -25.8% | -157.8% | -63.9% | -42.4% |
| Return on equity | -53.2% | -28.2% | 646.0% | -128.4% | -66.0% |
| Debt / equity | — | — | -0.00× | 0.48× | 0.23× |
| Current ratio | 8.07 | 12.94 | 0.74 | 4.76 | 5.89 |
| Revenue growth | — | — | — | -100.0% | -77.6% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 346,998 | $3.3M |
| Point72 Asset Management, L.P. | 51,296 | $481,669 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -0.98 (distress)
- Working capital / assets 0.87
- Retained earnings / assets -3.302
- EBIT / assets -0.507
- Equity / liabilities 7.129
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001595097 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.